Moreover, a recent systematic review analyzing 15 studies in breast cancer patients receiving chemotherapy reported that IL-6, IL-1β, and TNF-α were associated with varying degrees of cognitive impairment [98]. This evidence concerns the gene IL6 and breast carcinoma.